Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Duos Technologies (DUOT) Retained Earnings (2020 - 2025)

Duos Technologies has reported Retained Earnings over the past 12 years, most recently at -$84.2 million for Q4 2025.

  • Quarterly results put Retained Earnings at -$84.2 million for Q4 2025, down 13.22% from a year ago — trailing twelve months through Dec 2025 was -$84.2 million (down 13.22% YoY), and the annual figure for FY2025 was -$84.2 million, down 13.22%.
  • Retained Earnings for Q4 2025 was -$84.2 million at Duos Technologies, down from -$81.0 million in the prior quarter.
  • Over the last five years, Retained Earnings for DUOT hit a ceiling of -$39.9 million in Q1 2021 and a floor of -$84.2 million in Q4 2025.
  • Median Retained Earnings over the past 5 years was -$59.0 million (2023), compared with a mean of -$60.7 million.
  • Biggest five-year swings in Retained Earnings: dropped 13.22% in 2023 and later dropped 21.74% in 2024.
  • Duos Technologies' Retained Earnings stood at -$45.5 million in 2021, then dropped by 15.09% to -$52.4 million in 2022, then fell by 21.47% to -$63.6 million in 2023, then fell by 16.92% to -$74.4 million in 2024, then dropped by 13.22% to -$84.2 million in 2025.
  • The last three reported values for Retained Earnings were -$84.2 million (Q4 2025), -$81.0 million (Q3 2025), and -$80.0 million (Q2 2025) per Business Quant data.